This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Interactions

Authoring team

Allopurinol inhibits the metabolism of mercaptopurine which potentiates the affect of azathioprine and increases the risk of myelosuppression. The risk of myelosuppression is increased if there is concurrent use of other drugs that can cause a suppression of bone marrow.


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.